Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 479 | 3 | ADVANCED GLYCATION END PRODUCTS//METHYLGLYOXAL//HMGB1 | 24785 |
| 1674 | 2 | ADVANCED GLYCATION END PRODUCTS//METHYLGLYOXAL//GLYCATION | 7122 |
| 4788 | 1 | RAGE//RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS//SRAGE | 1753 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | RAGE | authKW | 2648317 | 20% | 41% | 357 |
| 2 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | authKW | 1798849 | 11% | 54% | 185 |
| 3 | SRAGE | authKW | 1120053 | 5% | 69% | 90 |
| 4 | SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS | authKW | 708436 | 3% | 77% | 51 |
| 5 | PATHOPHYSIOL THER EUT DIABET VASC COMPLIC | address | 499615 | 4% | 38% | 74 |
| 6 | BIOCHEM MOL VASC BIOL | address | 483208 | 3% | 54% | 50 |
| 7 | ADVANCED GLYCATION END PRODUCTS | authKW | 461102 | 12% | 12% | 214 |
| 8 | SOLUBLE RAGE | authKW | 460200 | 2% | 80% | 32 |
| 9 | RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS RAGE | authKW | 342588 | 2% | 53% | 36 |
| 10 | AGES | authKW | 340078 | 5% | 20% | 93 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Endocrinology & Metabolism | 2013 | 14% | 0% | 245 |
| 2 | Medicine, Research & Experimental | 1074 | 10% | 0% | 181 |
| 3 | Peripheral Vascular Diseases | 793 | 7% | 0% | 121 |
| 4 | Biochemistry & Molecular Biology | 773 | 21% | 0% | 368 |
| 5 | Cell Biology | 621 | 11% | 0% | 201 |
| 6 | Respiratory System | 405 | 5% | 0% | 80 |
| 7 | Cardiac & Cardiovascular System | 356 | 7% | 0% | 120 |
| 8 | Medical Laboratory Technology | 195 | 2% | 0% | 35 |
| 9 | Pharmacology & Pharmacy | 160 | 8% | 0% | 144 |
| 10 | Neurosciences | 152 | 8% | 0% | 141 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PATHOPHYSIOL THER EUT DIABET VASC COMPLIC | 499615 | 4% | 38% | 74 |
| 2 | BIOCHEM MOL VASC BIOL | 483208 | 3% | 54% | 50 |
| 3 | PATHOPHYSIOL SCI | 196404 | 3% | 21% | 53 |
| 4 | DIABET PROGRAM ENDOCRINOL | 115050 | 0% | 80% | 8 |
| 5 | PATHOPHYSIOL THER EUT DIABET VASC | 71908 | 0% | 100% | 4 |
| 6 | MED CLIN CHEM 1 | 49902 | 1% | 14% | 20 |
| 7 | LIFE PHARM | 49776 | 0% | 46% | 6 |
| 8 | RADIOISOTOPE BASIC CLIN MED | 47920 | 1% | 22% | 12 |
| 9 | INTER MOL MED CIRMC | 46353 | 0% | 37% | 7 |
| 10 | BIOL VASC CELLULAIRE | 38061 | 0% | 35% | 6 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CARDIOVASCULAR DIABETOLOGY | 1622 | 1% | 1% | 11 |
| 2 | DIABETES | 1553 | 2% | 0% | 33 |
| 3 | CURRENT MOLECULAR MEDICINE | 1216 | 1% | 1% | 9 |
| 4 | DIABETES-METABOLISM RESEARCH AND REVIEWS | 951 | 1% | 1% | 9 |
| 5 | JOURNAL OF DIABETES AND ITS COMPLICATIONS | 853 | 1% | 0% | 10 |
| 6 | ATHEROSCLEROSIS | 839 | 1% | 0% | 23 |
| 7 | MICROVASCULAR RESEARCH | 788 | 1% | 0% | 11 |
| 8 | MOLECULAR MEDICINE | 718 | 0% | 1% | 8 |
| 9 | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY | 713 | 1% | 0% | 9 |
| 10 | EXPERIMENTAL DIABESITY RESEARCH | 664 | 0% | 4% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |